Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies Regarding Violations of Current Good Manufacturing Practices Between 2017 and 2022

PURPOSE: Assessment of the US FDA-issued WLs content is an educational tool that can be used in the continuous training program of community pharmacists in compounding pharmacies. The study was designed to critically assess FDA warning letters (WLs) issued to compounding pharmacies in 2017–2022 for...

Descripción completa

Detalles Bibliográficos
Autor principal: Dmour, Isra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666930/
https://www.ncbi.nlm.nih.gov/pubmed/36407089
http://dx.doi.org/10.1007/s12247-022-09692-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9666930/
https://www.ncbi.nlm.nih.gov/pubmed/36407089
http://dx.doi.org/10.1007/s12247-022-09692-4

Ejemplares similares